Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance

PLoS Pathogens

Volumn 11, Issue 9, 2015, Pages

  Deymier, Martin J ^a   Ende, Zachary ^a   Fenton May, Angharad E ^b   Dilernia, Dario A ^a   Kilembe, William ^c   Allen, Susan A ^d   Borrow, Persephone ^b   Hunter, Eric ^a,d  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Zambia Emory HIV Research Project   (Zambia)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOCHROME P450 3A4; GAMMA INTERFERON; HISTONE DEACETYLASE; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; ANTIVIRUS AGENT;

ADULT; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL EVALUATION; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MOLECULAR CLONING; PATHOGENESIS; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; VIRUS NEUTRALIZATION; ANTIVIRAL RESISTANCE; CELL CULTURE; CLASSIFICATION; COHORT ANALYSIS; DENDRITIC CELL; DRUG EFFECTS; FAMILY SIZE; GENETIC VARIATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOLECULAR GENETICS; MOLECULAR TYPING; MONONUCLEAR CELL; PATHOLOGY; PHYLOGENY; PHYSIOLOGY; TRANSMISSION; VIRION; VIROLOGY; VIRUS ENTRY; VIRUS REPLICATION; ZAMBIA;

ANTIVIRAL AGENTS; CELLS, CULTURED; COHORT STUDIES; DENDRITIC CELLS; DRUG RESISTANCE, VIRAL; FAMILY CHARACTERISTICS; FEMALE; GENETIC VARIATION; HETEROSEXUALITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; PHYLOGENY; VIRION; VIRUS INTERNALIZATION; VIRUS REPLICATION; ZAMBIA;

EID: 84943547337     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005154     Document Type: Article

References (54)

1. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, et al. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science. 2004 Mar. 26;303(5666):2019–22. 15044802
2. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. P Natl Acad Sci Usa. 2008;105(21):7552–7.
3. Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, Karita E, Trkola A, et al. Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1. PLoS Pathog. 2009 Jan. 23;5(1):e1000274. doi: 10.1371/journal.ppat.1000274 19165325
4. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. Journal of Experimental Medicine. 2009 Jun. 8;206(6):1273–89. doi: 10.1084/jem.20090378 19487424
5. Boeras DI, Hraber PT, Hurlston M, Evans-Strickfaden T, Bhattacharya T, Giorgi EE, et al. Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proceedings of the National Academy of Sciences. 2011 Nov. 7.
6. Frange P, Meyer L, Jung M, Goujard C, Zucman D, Abel S, Mammano F, et al. Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner. Plos One. 2013 Jul. 9;8(7):e69144. doi: 10.1371/journal.pone.0069144 23874894
7. Carlson JM, Schaefer M, Monaco DC, Batorsky R, Claiborne DT, Prince J, et al. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science. 2014 Jul. 10;345(6193):1254031–1. doi: 10.1126/science.1254031 25013080
8. Sagar M, Laeyendecker O, Lee S, Gamiel J, Wawer MJ, Gray RH, et al. Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission. J Infect Dis. 2009 Feb. 15;199(4):580–9. doi: 10.1086/596557 19143562
9. Pena-Cruz V, Etemad B, Chatziandreou N, Nyein PH, Stock S, Reynolds SJ, et al. HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners. Retrovirology. 2013;10:162. doi: 10.1186/1742-4690-10-162 24369910
10. Nawaz F, Cicala C, van Ryk D, Block KE, Jelicic K, McNally JP, Trkola A, et al. The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7+/CD4+ T cells As Key Targets in Mucosal Transmission. PLoS Pathog. 2011 Feb. 24;7(2):e1001301. doi: 10.1371/journal.ppat.1001301 21383973
11. Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, Lapedes AS, Young JAT, et al. Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections. PLoS Pathog. 2011 Sep. 29;7(9):e1002209. doi: 10.1371/journal.ppat.1002209 21980282
12. Cavrois M, Neidleman J, Santiago ML, Derdeyn CA, Hunter E, Greene WC, Enhanced Fusion and Virion Incorporation for HIV-1 Subtype C Envelope Glycoproteins with Compact V1/V2 Domains. J Virol. 2013 Dec. 11.
13. Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, Parrish EH, et al. Phenotypic properties of transmitted founder HIV-1. Proceedings of the National Academy of Sciences. 2013 Apr. 23;110(17):6626–33.
14. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG, et al. Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages. J Virol. 2012 Feb. 11;86(5):2715–28. doi: 10.1128/JVI.06157-11 22190722
15. Liu Y, Curlin ME, Diem K, Zhao H, Ghosh AK, Zhu H, et al. Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology. 2008 May;374(2):229–33. doi: 10.1016/j.virol.2008.01.029 18314154
16. Baalwa J, Wang S, Parrish NF, Decker JM, Keele BF, Learn GH, et al. Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. Virology. 2012 Nov.
17. Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman MM, et al. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology. 2013;10:146. doi: 10.1186/1742-4690-10-146 24299076
18. Frost SDW, Liu Y, Pond SLK, Chappey C, Wrin T, Petropoulos CJ, et al. Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B. J Virol. 2005 Apr. 27;79(10):6523–7. 15858036
19. Chohan B, Lang D, Sagar M, Korber B, Lavreys L, Richardson B, et al. Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels. J Virol. 2005 Apr. 27;79(10):6528–31. 15858037
20. van't Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. Journal of Clinical Investigation. 1994 Nov.;94(5):2060–7. 7962552
21. Richardson SI, Gray ES, Mkhize NN, Sheward DJ, Lambson BE, Wibmer CK, et al. South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication. Retrovirology. BioMed Central; 2015 Jun. 23;:1–16.
22. Redd AD, Collinson-Streng AN, Chatziandreou N, Mullis CE, Laeyendecker O, Martens C, et al. Previously Transmitted HIV-1 Strains Are Preferentially Selected During Subsequent Sexual Transmissions. J Infect Dis. 2012 Oct. 8;206(9):1433–42. doi: 10.1093/infdis/jis503 22997233
23. Isaacman-Beck J, Hermann EA, Yi Y, Ratcliffe SJ, Mulenga J, Allen S, et al. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J Virol. 2009 Aug.;83(16):8208–20. doi: 10.1128/JVI.00296-09 19515785
24. Alexander M, Lynch R, Mulenga J, Allen S, Derdeyn CA, Hunter E, Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry. J Virol. 2010 Apr.;84(8):4100–4. doi: 10.1128/JVI.02068-09 20147398
25. Parrish NF, Wilen CB, Banks LB, Iyer SS, Pfaff JM, Salazar-Gonzalez JF, Trkola A, et al. Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7. PLoS Pathog. 2012 May 31;8(5):e1002686. doi: 10.1371/journal.ppat.1002686 22693444
26. Deymier MJ, Claiborne DT, Ende Z, Ratner HK, Kilembe W, Allen S, et al. Particle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloning. Virology. 2014 Sep. 19;468-470C:454–61.
27. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, et al. Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy. Antimicrobial Agents and Chemotherapy. 2002 Jun. 1;46(6):1896–905. 12019106
28. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al. Antibody neutralization and escape by HIV-1. Nature. 2003 Mar. 20;422(6929):307–12. 12646921
29. Hu J, Gardner MB, Miller CJ, Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol. 2000 Jul.;74(13):6087–95. 10846092
30. Ping LH, Joseph SB, Anderson JA, Abrahams MR, Salazar-Gonzalez JF, Kincer LP, et al. Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design. J Virol. 2013 Jun. 10;87(13):7218–33. doi: 10.1128/JVI.03577-12 23616655
31. Alizon S, Fraser C, Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology. 2013;10:49. 23639104
32. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991 Dec. 12;354(6353):453–9. 1721107
33. Richman DD, Wrin T, Little SJ, Petropoulos CJ, Rapid evolution of the neutralizing antibody response to HIV type 1 infection. P Natl Acad Sci Usa. 2003 Apr. 1;100(7):4144–9.
34. Wilen CB, Parrish NF, Pfaff JM, Decker JM, Henning EA, Haim H, et al. Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins. J Virol. 2011 Aug. 8;85(17):8514–27. doi: 10.1128/JVI.00736-11 21715507
35. Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, Lifson J, et al. Role of Transmitted Gag CTL Polymorphisms in Defining Replicative Capacity and Early HIV-1 Pathogenesis. PLoS Pathog. 2012 Nov. 29;8(11):e1003041. doi: 10.1371/journal.ppat.1003041 23209412
36. Wright JK, Brumme ZL, Carlson JM, Heckerman D, Kadie CM, Brumme CJ, et al. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. J Virol. 2010 Oct.;84(20):10820–31. doi: 10.1128/JVI.01084-10 20702636
37. Yue L, Pfafferott KJ, Baalwa J, Conrod K, Dong CC, Chui C, Douek DC, et al. Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients. PLoS Pathog. 2015 Jan. 8;11(1):e1004565. doi: 10.1371/journal.ppat.1004565 25569444
38. Claiborne DT, Prince JL, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4 +T cells, and disease progression. Proceedings of the National Academy of Sciences. 2015 Feb. 17;:201421607.
39. Rouzine IM, Weinberger AD, Weinberger LS, An Evolutionary Role for HIV Latency in Enhancing Viral Transmission. Cell. Elsevier Inc; 2015 Feb. 26;160(5):1002–12.
40. Abel K, Rocke DM, Chohan B, Fritts L, Miller CJ, Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol. 2005 Oct.;79(19):12164–72. 16160143
41. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009 Mar. 4;458(7241):1034–8. doi: 10.1038/nature07831 19262509
42. Etienne L, Hahn BH, Sharp PM, Matsen FA, Emerman M, Gene Loss and Adaptation to Hominids Underlie the Ancient Origin of HIV-1. Cell Host Microbe. Elsevier Inc; 2013 Jul. 17;14(1):85–92.
43. Sandler NG, Bosinger SE, Estes JD, Zhu RTR, Tharp GK, Boritz E, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature. Nature Publishing Group; 2014 Jul. 22;511(7511):601–5.
44. Shirazi Y, Pitha PM, Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J Virol. 1992 Mar.;66(3):1321–8. 1738192
45. Künzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM, Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis. 1995 Apr.;171(4):822–8. 7706808
46. Edlin BR, St Clair MH, Pitha PM, Whaling SM, King DM, Bitran JD, et al. In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann. Intern. Med. 1992 Sep. 15;117(6):457–60. 1503348
47. Trask SA, Derdeyn CA, Fideli U, Chen Y, Meleth S, Kasolo F, et al. Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia. J Virol. 2002 Jan.;76(1):397–405. 11739704
48. Rousseau CM, Birditt BA, McKay AR, Stoddard JN, Lee TC, McLaughlin S, et al. Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. J. Virol. Methods. 2006 Sep.;136(1–2):118–25. 16701907
49. Dilernia DA, Chien JT, Monaco DC, Brown MPS, Ende Z, Deymier MJ, et al. Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing. Nucleic Acids Res. 2015 Jun. 22. doi: 10.1093/nar/gkv630
50. Edgar RC, MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004 Mar. 8;32(5):1792–7. 15034147
51. Deng W, Maust B, Nickle D, Learn G, Liu Y, Heath L, et al. DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites. Biotech. 2010 May;48(5):405–8.
52. Nickle DC, Heath L, Jensen MA, Gilbert PB, Mullins JI, Kosakovsky Pond SL, Pybus O, HIV-Specific Probabilistic Models of Protein Evolution. Plos One. 2007 Jun. 6;2(6):e503. 17551583
53. Claiborne DT, Prince JL, Hunter E, A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses. JoVE (Journal of Visualized Experiments). 2014;(90):e51506–6.
54. Dugast A-S, Chan Y, Hoffner M, Licht A, Nkolola J, Li H, et al. Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodies. Plos One. 2014;9(5):e97229. doi: 10.1371/journal.pone.0097229 24820481